21 CFR 830.60
Relabeling of a device that is required to bear a unique device identifier
21 CFR 830.60 is the regulation titled “Relabeling of a device that is required to bear a unique device identifier” in 21 CFR Part 830, Unique Device Identification. Since 2021, 1 FDA warning letter has cited it.
- Letters citing it
- 1 since 2021
- Jan 1 to Oct 30, 2026
- 0 against 0 on the same dates in 2025
- Most often cited with
- 21 CFR 801.20, in 1 letter
- Closed out
- 100% of these letters have a published close-out
Letters citing it, by year issued
It is a medical device letter. 2026 runs to Oct 30, 2026. Pick a year to see its letters.
- 02021
- 12022
- 02023
- 02024
- 02025
- 02026
What FDA writes when it cites it
The finding headings that cite 21 CFR 830.60 most often, as written in the letters.
- 1 letterFailure to ensure that the label of every medical device shall bear a unique device identifier (UDI) that meets the requirements of 21 CFR 801 Subpart B and 21 CFR Part 830, as required by 21 CFR 801.20(a)
The regulation
Read the text of 21 CFR 830.60 (eCFR, as of Sep 1, 2026)
If you relabel a device that is required to bear a unique device identifier (UDI), you must:
(a) Assign a new device identifier to the device, and
(b) Keep a record showing the relationship of the prior device identifier to your new device identifier.
[78 FR 58825, Sept. 24, 2013]
Text from eCFR as of Sep 1, 2026.
Cited alongside it
Regulations that appear in the same letters as 21 CFR 830.60.
- 21 CFR 801.20Label to bear a unique device identifier1 letter cites both
- 21 CFR 801.3Definitions1 letter cites both
- 21 CFR 820.120Device labeling1 letter cites both
- 21 CFR 820.181Device master record1 letter cites both
- 21 CFR 820.200Servicing1 letter cites both
- 21 CFR 820.40Document controls1 letter cites both
- 21 CFR 820.80Receiving, in-process, and finished device acceptance1 letter cites both
- 21 CFR 830.300Devices subject to device identification data submission requirements1 letter cites both
Latest letters citing it
The letter citing 21 CFR 830.60 that FDA posted most recently.
See the letter citing 21 CFR 830.60 →Put this kind of reading to
work on your own records.
Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.
Counts include every citation in a letter, as the Letters filter does. How this database is built.